Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.970
-0.010 (-0.34%)
Jan 22, 2025, 12:06 PM EST - Market open
Puma Biotechnology Employees
Puma Biotechnology had 185 employees as of December 31, 2023. The number of employees decreased by 7 or -3.65% compared to the previous year.
Employees
185
Change (1Y)
-7
Growth (1Y)
-3.65%
Revenue / Employee
$1,316,589
Profits / Employee
$125,627
Market Cap
145.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PBYI News
- 18 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Puma Biotechnology's NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation - Business Wire
- 5 weeks ago - Puma Biotechnology: Continuing To Push Their Aurora Kinase Story Forward - Seeking Alpha
- 2 months ago - Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer - Business Wire
- 2 months ago - Puma Biotechnology, Inc. (PBYI) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Puma Biotechnology Reports Third Quarter 2024 Financial Results - Business Wire
- 3 months ago - Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - Business Wire
- 5 months ago - Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire